Vijay Kumar
Stock Analyst at Evercore ISI Group
(3.49)
# 881
Out of 4,650 analysts
184
Total ratings
56.6%
Success rate
1.73%
Average return
Main Sectors:
Stocks Rated by Vijay Kumar
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TMO Thermo Fisher | Maintains: Outperform | $630 → $620 | $552.54 | +12.21% | 10 | Oct 24, 2024 | |
| ISRG Intuitive Surgical | Maintains: In-Line | $475 → $490 | $510.88 | -4.09% | 11 | Oct 18, 2024 | |
| JBHT J.B. Hunt Transport Services | Maintains: Outperform | $183 → $185 | $178.88 | +3.42% | 5 | Oct 16, 2024 | |
| BLCO Bausch + Lomb | Upgrades: Outperform | $19 → $25 | $20.37 | +22.73% | 7 | Oct 15, 2024 | |
| USB U.S. Bancorp | Maintains: In-Line | $49 → $51 | $48.59 | +4.96% | 3 | Oct 2, 2024 | |
| ZBH Zimmer Biomet Holdings | Maintains: In-Line | $113 → $110 | $103.60 | +6.18% | 12 | Oct 1, 2024 | |
| WAT Waters | Maintains: In-Line | $335 → $355 | $325.51 | +9.06% | 8 | Oct 1, 2024 | |
| TWST Twist Bioscience | Maintains: Outperform | $52 → $56 | $42.52 | +31.70% | 5 | Oct 1, 2024 | |
| SYK Stryker | Maintains: Outperform | $365 → $380 | $356.01 | +6.74% | 8 | Oct 1, 2024 | |
| NVCR NovoCure | Maintains: In-Line | $21 → $18 | $16.62 | +8.30% | 10 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: In-Line | $1,375 → $1,450 | $1,294.92 | +11.98% | 7 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $120 → $160 | $112.90 | +41.72% | 7 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $100 → $104 | $90.60 | +14.79% | 4 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: In-Line | $78 → $82 | $80.46 | +1.91% | 12 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $98 → $102 | $85.93 | +18.70% | 3 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $72 → $80 | $69.35 | +15.36% | 2 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: In-Line | $76 → $70 | $68.52 | +2.16% | 10 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $62 → $58 | $41.17 | +40.88% | 3 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $275 → $278 | $244.12 | +13.88% | 2 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $82 → $90 | $84.76 | +6.18% | 5 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $286 → $290 | $238.91 | +21.38% | 6 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: In-Line | $53 → $50 | $41.91 | +19.30% | 5 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $120 → $124 | $114.07 | +8.71% | 10 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: In-Line | $135 → $145 | $131.54 | +10.23% | 2 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: In-Line | $4.5 → $5 | $4.16 | +20.19% | 3 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $46 → $45 | $36.01 | +24.97% | 6 | Jul 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $28 → $27 | $22.64 | +19.26% | 10 | Jul 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $195 → $175 | $144.03 | +21.50% | 6 | Jun 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $88 → $125 | $117.49 | +6.39% | 1 | Jan 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $7 | $0.97 | +621.65% | 1 | May 31, 2022 |
Thermo Fisher
Oct 24, 2024
Maintains: Outperform
Price Target: $630 → $620
Current: $552.54
Upside: +12.21%
Intuitive Surgical
Oct 18, 2024
Maintains: In-Line
Price Target: $475 → $490
Current: $510.88
Upside: -4.09%
J.B. Hunt Transport Services
Oct 16, 2024
Maintains: Outperform
Price Target: $183 → $185
Current: $178.88
Upside: +3.42%
Bausch + Lomb
Oct 15, 2024
Upgrades: Outperform
Price Target: $19 → $25
Current: $20.37
Upside: +22.73%
U.S. Bancorp
Oct 2, 2024
Maintains: In-Line
Price Target: $49 → $51
Current: $48.59
Upside: +4.96%
Zimmer Biomet Holdings
Oct 1, 2024
Maintains: In-Line
Price Target: $113 → $110
Current: $103.60
Upside: +6.18%
Waters
Oct 1, 2024
Maintains: In-Line
Price Target: $335 → $355
Current: $325.51
Upside: +9.06%
Twist Bioscience
Oct 1, 2024
Maintains: Outperform
Price Target: $52 → $56
Current: $42.52
Upside: +31.70%
Stryker
Oct 1, 2024
Maintains: Outperform
Price Target: $365 → $380
Current: $356.01
Upside: +6.74%
NovoCure
Oct 1, 2024
Maintains: In-Line
Price Target: $21 → $18
Current: $16.62
Upside: +8.30%
Oct 1, 2024
Maintains: In-Line
Price Target: $1,375 → $1,450
Current: $1,294.92
Upside: +11.98%
Oct 1, 2024
Maintains: Outperform
Price Target: $120 → $160
Current: $112.90
Upside: +41.72%
Oct 1, 2024
Maintains: Outperform
Price Target: $100 → $104
Current: $90.60
Upside: +14.79%
Oct 1, 2024
Maintains: In-Line
Price Target: $78 → $82
Current: $80.46
Upside: +1.91%
Oct 1, 2024
Maintains: Outperform
Price Target: $98 → $102
Current: $85.93
Upside: +18.70%
Oct 1, 2024
Maintains: Outperform
Price Target: $72 → $80
Current: $69.35
Upside: +15.36%
Oct 1, 2024
Maintains: In-Line
Price Target: $76 → $70
Current: $68.52
Upside: +2.16%
Oct 1, 2024
Maintains: Outperform
Price Target: $62 → $58
Current: $41.17
Upside: +40.88%
Oct 1, 2024
Maintains: Outperform
Price Target: $275 → $278
Current: $244.12
Upside: +13.88%
Oct 1, 2024
Maintains: Outperform
Price Target: $82 → $90
Current: $84.76
Upside: +6.18%
Oct 1, 2024
Maintains: Outperform
Price Target: $286 → $290
Current: $238.91
Upside: +21.38%
Oct 1, 2024
Maintains: In-Line
Price Target: $53 → $50
Current: $41.91
Upside: +19.30%
Oct 1, 2024
Maintains: Outperform
Price Target: $120 → $124
Current: $114.07
Upside: +8.71%
Oct 1, 2024
Maintains: In-Line
Price Target: $135 → $145
Current: $131.54
Upside: +10.23%
Aug 7, 2024
Maintains: In-Line
Price Target: $4.5 → $5
Current: $4.16
Upside: +20.19%
Jul 2, 2024
Maintains: Outperform
Price Target: $46 → $45
Current: $36.01
Upside: +24.97%
Jul 2, 2024
Maintains: Outperform
Price Target: $28 → $27
Current: $22.64
Upside: +19.26%
Jun 11, 2024
Maintains: Outperform
Price Target: $195 → $175
Current: $144.03
Upside: +21.50%
Jan 4, 2024
Upgrades: Outperform
Price Target: $88 → $125
Current: $117.49
Upside: +6.39%
May 31, 2022
Initiates: Outperform
Price Target: $7
Current: $0.97
Upside: +621.65%